MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Remote physical activity monitoring programs for Veterans with Parkinson’s disease

    K. Waddell, M. Patel, J. Wilkinson, S. Koganti, S. Wood, J. Morley (Philadelphia, USA)

    Objective: To examine feasibility of a remote physical activity monitoring program and predictors of activity among rural Veterans with PD Background: Patients in rural areas,…
  • 2022 International Congress

    TRPV4 Mutation related Parkinson’s Disease with Scapuloperoneal spinal muscular atrophy

    A. Deenadayalu, P. A, V. Paramanandam (Limerick, Ireland)

    Objective: Scapuloperoneal spinal muscular atrophy (SPSMA) is a rare autosomal dominant disease caused by transient receptor potential cation channel (TRPV4) gene, involving scapular and peroneal…
  • 2022 International Congress

    Functional dystonia on a 46 year-old woman

    F. Rivas, I. Rodríguez, D. Vázquez (San Luis Potosí, Mexico)

    Objective: To report a case of a 46 six years-old woman presenting with functional dystonia Background: Nowadays we use the term dystonia when we are…
  • 2022 International Congress

    Can membrane association of α-synuclein aggregates lead to stress in the astrocytic endoplasmic reticulum?

    A. Raj, I. Datta, R. Banerjee (Bangalore, India)

    Objective: To study the association extracellularly added wildtype-WT and A30P/A53T mutant α-synuclein aggregates with the astrocytic membrane and to evaluate the effect of these peptides…
  • 2022 International Congress

    IkT-148009 as a potential disease-modifying therapy in PD

    M. Werner, S. Karuppagounder, R. Rush, T. Kelly, T. Dawson, V. Dawson (Atlanta, USA)

    Objective: Modeling Parkinson’s disease in mice suggests c-Abl activation is required for PD initiation and progression, and therefore inhibition of c-Abl could be a strategy…
  • 2022 International Congress

    Validation of a patient-reported functional mobility composite score (FMCS) in people with typical Parkinson’s disease

    AMH. Hanff, A. Rauschenberger, C. Mccrum, G. Aguayo, M. Zeegers, A. Leist, R. Krüger (Strassen, Luxembourg)

    Objective: To investigate the convergent and discriminative validity of a patient-reported FMCS in people with typical PD (PwP). Background: Although a patient-reported instrument is less…
  • 2022 International Congress

    Outcome measurement and goal setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin

    J. Jacinto, A. Camões Barbosa, S. Carda, D. Hoad, J. Wissel (Alcabideche, Portugal)

    Objective: To present expert consensus on choice of outcome measurement scales and goal setting recommendations for botulinum neurotoxin (BoNT) in the treatment of shoulder spasticity…
  • 2022 International Congress

    The efficacy of Botulinum toxin A in reducing muscle spasticity by different volumes of dilution

    R. Marvulli, G. Ianieri, G. Mintrone, A. Zonno, L. Rizzo, G. Farì, M. Ranieri, M. Megna (Bari, Italy)

    Objective: Spasticity is a speed-dependent increase in muscle tone associated with stiffness, enhanced osteotendinous reflexes, paresis, loss of fine motor control, and increased fatigue. The…
  • 2022 International Congress

    Cognitive dysfunction in cervical dystonia

    M. Diepman, S. Rafee, M. Hutchinson, R. Sommers, F. O'Keeffe (Dublin 4, Ireland)

    Objective: To assess prevalence of anxiety and depression in patients with CD and investigate cognitive changes including social cognition and executive function. Background: Cervical dystonia,…
  • 2022 International Congress

    The Genetic Landscape of Parkinson’s disease in populations of non-Caucasian ancestry.

    C. Koros, AM. Simitsi, N. Papagiannakis, A. Bougea, I. Pachi, R. Antonelou, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: We aimed to review existing literature on the genetic background of Parkinson’s disease (PD) populations of non-Caucasian or mixed ancestry. Background: There has been…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley